Lista de obras -

A four-gene signature predicts disease progression in muscle invasive bladder cancer.

artículo científico publicado en 2011

A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer

scientific article published on 19 November 2019

A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone

artículo científico publicado en 2020

A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer

artículo científico publicado en 2020

Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: A novel approach using peptide nucleic acid-mediated, real-time PCR clamping ⬇️

artículo científico publicado el 29 de septiembre de 2010

Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis

artículo científico publicado en 2015

Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression

artículo científico publicado en 2004

Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer

artículo científico

Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer

artículo científico publicado en 2009

Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.

artículo científico

Diagnosis of bladder cancer and prediction of survival by urinary metabolomics

artículo científico publicado en 2014

Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria

artículo científico publicado en 2018

Erratum: Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue

artículo científico publicado en 2016

Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation status

artículo científico publicado en 2017

GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer

artículo científico publicado en 2011

GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer.

scientific article published on January 2010

Garlic extract in bladder cancer prevention: Evidence from T24 bladder cancer cell xenograft model, tissue microarray, and gene network analysis

artículo científico

Generation of Whole-Genome Sequencing Data for Comparing Primary and Castration-Resistant Prostate Cancer

Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer

artículo científico publicado en 2017

Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer

artículo científico publicado en 2005

Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer.

artículo científico publicado en 2018

Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.

artículo científico publicado en 2012

Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue

artículo científico publicado en 2016

Kinesin Family Member 11 mRNA Expression Predicts Prostate Cancer Aggressiveness

artículo científico publicado en 2016

Long-term validation of a molecular progression-associated gene classifier for prediction of muscle invasion in primary non-muscle-invasive bladder cancer

artículo científico publicado en 2017

Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls

scientific article published on July 2016

Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor

artículo científico publicado en 2008

Molecular Progression Risk Score for Prediction of Muscle Invasion in Primary T1 High-Grade Bladder Cancer

artículo científico publicado en 2018

Negative Effect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer

scientific article published on 23 September 2020

Novel combination markers for predicting progression of nonmuscle invasive bladder cancer.

artículo científico

Novel combination markers for predicting survival in patients with muscle invasive bladder cancer: USP18 and DGCR2.

artículo científico publicado en 2014

Parathyroid hormone is associated with prostate cancer

scientific article published on 26 February 2020

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

artículo científico publicado en 2010

RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

artículo científico publicado en 2005

Runt-related transcription factor 3 methylation as a possible prognosticator in muscle-invasive bladder cancer.

artículo científico publicado en 2011

The Anticancer Effects of Garlic Extracts on Bladder Cancer Compared to Cisplatin: A Common Mechanism of Action via Centromere Protein M.

artículo científico publicado en 2018

Three-gene signature predicts disease progression of non-muscle invasive bladder cancer.

artículo científico publicado en 2011

Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer

artículo científico publicado en 2017

Tumorigenic and prognostic significance of RASSF1A expression in low-grade (WHO grade 1 and grade 2) nonmuscle-invasive bladder cancer.

artículo científico

UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria

artículo científico publicado en 2016

Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer

artículo científico publicado en 2019

Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers

artículo científico publicado en 2015

Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer

artículo científico publicado en 2015

Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria

artículo científico publicado en 2018

Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer.

artículo científico publicado en 2018

Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer

artículo científico publicado en 2016

mRNA Expression Is Associated with the Aggressiveness of Prostate Cancer

scientific article published on 02 November 2018

Lista de obras de

A four-gene signature predicts disease progression in muscle invasive bladder cancer.

A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer

A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone

A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer

Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: A novel approach using peptide nucleic acid-mediated, real-time PCR clamping ⬇️

Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis

Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression

Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer

Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer

Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.

Diagnosis of bladder cancer and prediction of survival by urinary metabolomics

Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria

Erratum: Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue

Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation status

GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer

GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer.

Garlic extract in bladder cancer prevention: Evidence from T24 bladder cancer cell xenograft model, tissue microarray, and gene network analysis

Generation of Whole-Genome Sequencing Data for Comparing Primary and Castration-Resistant Prostate Cancer

Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer

Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer

Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer.

Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.

Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue

Kinesin Family Member 11 mRNA Expression Predicts Prostate Cancer Aggressiveness

Long-term validation of a molecular progression-associated gene classifier for prediction of muscle invasion in primary non-muscle-invasive bladder cancer

Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls

Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor

Molecular Progression Risk Score for Prediction of Muscle Invasion in Primary T1 High-Grade Bladder Cancer

Negative Effect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer

Novel combination markers for predicting progression of nonmuscle invasive bladder cancer.

Novel combination markers for predicting survival in patients with muscle invasive bladder cancer: USP18 and DGCR2.

Parathyroid hormone is associated with prostate cancer

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

Runt-related transcription factor 3 methylation as a possible prognosticator in muscle-invasive bladder cancer.

The Anticancer Effects of Garlic Extracts on Bladder Cancer Compared to Cisplatin: A Common Mechanism of Action via Centromere Protein M.

Three-gene signature predicts disease progression of non-muscle invasive bladder cancer.

Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer

Tumorigenic and prognostic significance of RASSF1A expression in low-grade (WHO grade 1 and grade 2) nonmuscle-invasive bladder cancer.

UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria

Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer

Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers

Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer

Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria

Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer.

Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer

mRNA Expression Is Associated with the Aggressiveness of Prostate Cancer